Veradermics, Inc
MANE- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001827635
In the last 90 days, Veradermics, Inc insiders filed 0 open-market purchases and 4 sales; 164 institutions reported holding it in 13F filings for Q2 2026, worth $4.17B in total; superinvestors Viking Global Investors and Maverick Capital hold it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsLast 90 days, $103.1M in total
- 4
- 13F holdersQ2 2026, +83 vs. previous quarter
- 164
- 13F valueReported value at the end of Q2 2026
- $4.17B
- Superinvestors holdingAt the end of Q2 2026
- 2
Price chart
Superinvestors holding MANE, Q2 2026
2 superinvestors report holding Veradermics, Inc on Form 13F. Percentages are the stock's share of each portfolio.
Viking Global Investors
Andreas Halvorsen
0.5%
Veradermics, Inc's share of the portfolio
- Shares
- 1,561,494
- Value
- $192.0M
Latest insider trades
Open-market purchases and sales by Veradermics, Inc insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 21, 2026 (view filing)6:11 PM ET | Aug 19 | 2 days | Montanova Capital, LLC and 3 othersDirector | SSaleCommon stock, par value $0.00001 per share | −750.0K | $107.25 | −$80.4M | −61.9%461.0K after | 2 lots |
| Aug 18, 2026 (view filing)9:10 PM ET | Aug 17 | 1 day | Durso Timothy AugustChief Technical Officer | SSale | −43.5K | $107.82 | −$4.69M | −35.8%78.1K after | 5 lots10b5-1 |
| Aug 18, 2026 (view filing)9:04 PM ET | Aug 17 | 1 day | Waldman Reid AlexanderChief Executive Officer | SSale | −67.5K | $107.86 | −$7.28M | −28.3%170.8K after | 5 lots10b5-1 |
| Aug 14, 2026 (view filing)6:01 PM ET | Aug 12 | 2 days | Childs John WDirector | SSale | −100.0K | $107.12 | −$10.7M | −34.0%194.1K after | 3 lots |
| Feb 27, 2026 (view filing) | Feb 5 | 22 days | Childs John WDirector | PPurchase | +294.1K | $17.00 | +$5.00M | New position294.1K after | Amended |
| Feb 9, 2026 (view filing)6:28 PM ET | Feb 4-6 | 5 daysLate | Montanova Capital, LLC and 3 othersDirector, 10% Owner | PPurchaseCommon stock, par value $0.00001 per share | +282.7K | $37.30 | +$10.5M | +118.9%520.5K after | 19 lots |
| Feb 5, 2026 (view filing)7:03 PM ET | Feb 5 | Same day | Longitude Venture Partners V, L.P. and 3 others10% Owner | PPurchase | +1.07M | $17.00 | +$18.3M | +109.9%2.05M after | 2 lotsDuplicate filing |
| Feb 5, 2026 (view filing) | Feb 5 | Same day | Coric VladDirector | PPurchase | +117.6K | $17.00 | +$2.00M | +58.3%319.4K after | 2 lots |
| Feb 5, 2026 (view filing) | Feb 5 | Same day | Enright Patrick GDirector, 10% Owner | PPurchase | +1.07M | $17.00 | +$18.3M | +109.9%2.05M after | 2 lots |
Top 10 13F holders, Q2 2026
The largest institutional positions in Veradermics, Inc at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Suvretta Capital Management, LLC | 4,168,970 | $512.5M | 10.77% | 00.0% | Unchanged |
| FMR LLC | 3,204,981 | $394.0M | 0.02% | +1,412,072+78.8% | Added |
| Sr One Capital Management, LP | 2,401,868 | $295.3M | 28.42% | 00.0% | Unchanged |
| Deep Track Capital, LP | 2,000,000 | $245.9M | 3.62% | +1,500,000+300.0% | Added |
| Citadel Advisors LLC | 1,877,775 | $230.9M | 0.13% | +52,103+2.9% | Added |
| Siren, L.L.C. | 1,655,374 | $203.5M | 4.13% | +150,000+10.0% | Added |
| BlackRock, Inc. | 1,593,791 | $195.9M | 0.00% | +1,311,180+464.0% | Added |
| Viking Global Investors LPSuperinvestorViking Global Investors | 1,561,494 | $192.0M | 0.55% | −129,061−7.6% | Reduced |
| JPMorgan Chase & Co | 1,165,584 | $144.2M | 0.01% | +189,418+19.4% | Added |
| Standard Life Aberdeen plc | 1,096,642 | $134.8M | 0.19% | +41,982+4.0% | Added |